ALAIN J. COHEN

Insider Reports History

Location
Bethesda, MD
Signature
/s/ Jolie M. Siegel, Attorney-in-Fact
All insider transactions
Transactions in reports broken out by “transaction date” reported in original SEC filing, see here for transactions aggregated across transaction date

Holdings reported by ALAIN J. COHEN:

Company Role Class Num Shares Value Price $ Report Date Ownership
C4 Therapeutics, Inc. Director Common Stock 1,804,324 $11,764,192 $6.52 04 Apr 2022 By Alain J. Cohen Revocable Trust
C4 Therapeutics, Inc. Director Common Stock 928 $6,051 $6.52 04 Apr 2022 Direct
C4 Therapeutics, Inc. Director Stock Option (Right to Buy) 23,500 15 Jun 2021 Direct

Insider Reports Filed by ALAIN J. COHEN

Symbol Company Period Transactions Value $ Form Type Role Filing Time
CCCC C4 Therapeutics, Inc. 04 Apr 2022 1 +$10,266 4 Director 05 Apr 2022, 16:26
CCCC C4 Therapeutics, Inc. 04 Jan 2022 1 +$10,042 4 Director 18 Jan 2022, 15:30
CCCC C4 Therapeutics, Inc. 04 Oct 2021 1 +$9,988 4 Director 05 Oct 2021, 16:54
CCCC C4 Therapeutics, Inc. 02 Jul 2021 1 +$9,970 4 Director 07 Jul 2021, 16:30
CCCC C4 Therapeutics, Inc. 15 Jun 2021 1 $0 4 Director 17 Jun 2021, 16:15
CCCC C4 Therapeutics, Inc. 14 Jun 2021 2 $0 4 Director 14 Jun 2021, 17:16